STRATEGIC PARTNERSHIPS
A key element of our strategy is to establish strategic alliances with leading pharmaceutical and biotechnology companies. We are currently collaborating with Pfizer in a research program focusing on three specific sodium channel targets . This collaboration provides us with an opportunity to extend our ion channel drug discovery technology into additional therapeutic areas and to benefit from the research, development and commercialization capabilities of our collaborators, as well as to augment our financial resources.
|
|
